← All stocks

Ovid Therapeutics Inc.

OVID Net selling
CIK 0001636651 #3040 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$29.29K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$29.29K
2 of 2 sales
Net
−$29.29K
−$29.29K against sales at will

By person

8 insiders · 3 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ALEXANDER MARGARET A.
President and CEO
$16.90K (1)
−$16.90K
61,750
$89.54K
+119.6%
Rona Jeffrey A
CBFO
$12.38K (1)
−$12.38K
156,313
$226.65K
+174.8%
TAKEDA PHARMACEUTICAL CO LTD entity
10% owner
7,000,000
$10.15M
+21.7%
LEVIN JEREMY M
Executive Chairman
3,735,048
$5.42M
+3.3%
PAPADOPOULOS STELIOS
Director
217,578
$315.49K
+8.8%
Carter Charles Ross
Chief Financial Officer
94,375
$136.84K
+112.7%
Fitzgerald Kevin Joseph
Director
17,578
$25.49K
Friedman Bart
Director
8,789
$12.74K

No percentages here. This company's share count has moved by a factor of 2.8 over the window, from 71,009,866 to 195,297,857 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 17
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 1,530,403
History held since 10 May 2017